Literature DB >> 25442121

Molecular pathogenesis of alpha-1-antitrypsin deficiency.

A Duvoix1, B D Roussel1, D A Lomas2.   

Abstract

Alpha-1 antitrypsin (α1-AT) is the most abundant circulating protease inhibitor. The common severe Z allele of α1-AT (Glu342Lys) causes the protein to form ordered polymers that are retained within the endoplasmic reticulum of hepatocytes. These polymers form the periodic acid-Schiff positive inclusions that are associated with cirrhosis. The lack of circulating α1-AT predisposes the Z α1-AT homozygote to early onset emphysema. We review here the molecular basis of α1-AT deficiency and show how understanding the liver disease provides new insights in the pathobiology of the associated emphysema. The mechanism of α1-AT deficiency provides a paradigm for a wider group of conditions that we have termed the serpinopathies. We also examine the strategies that are being pursued to develop novel therapies for α1-AT deficiency. This review considers our understanding of the pathobiology of α1-AT deficiency and then illustrate the therapeutic possibilities that can ensue once we understand basic mechanisms of disease.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alpha-1 antitrypsin deficiency; Conformational disease; Défaut de repliement; Déficit en alpha-1 antitrypsine; Liver disease; Maladie hépatique; Maladies conformationnelles; Misfolding; Protein evolution; Évolution protéique

Mesh:

Substances:

Year:  2014        PMID: 25442121     DOI: 10.1016/j.rmr.2014.03.015

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  6 in total

1.  Don't Miss the BoAAT: Correctly Diagnosing Acute-on-Chronic Liver Disease.

Authors:  Zain A Sobani; Graziella R Paniz; Morgan Wong; Denis M McCarthy
Journal:  Dig Dis Sci       Date:  2019-10       Impact factor: 3.199

2.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

Review 3.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

4.  A Novel Small Molecule Inhibits Intrahepatocellular Accumulation of Z-Variant Alpha 1-Antitrypsin In Vitro and In Vivo.

Authors:  Xiaojuan Zhang; Kien Pham; Danmeng Li; Ryan J Schutte; David Hernandez Gonzalo; Penghui Zhang; Regina Oshins; Weihong Tan; Mark Brantly; Chen Liu; David A Ostrov
Journal:  Cells       Date:  2019-12-06       Impact factor: 6.600

5.  hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α1-antitrypsin deficiency.

Authors:  Charis-Patricia Segeritz; Sheikh Tamir Rashid; Miguel Cardoso de Brito; Maria Paola Serra; Adriana Ordonez; Carola Maria Morell; Joseph E Kaserman; Pedro Madrigal; Nicholas R F Hannan; Laurent Gatto; Lu Tan; Andrew A Wilson; Kathryn Lilley; Stefan J Marciniak; Bibek Gooptu; David A Lomas; Ludovic Vallier
Journal:  J Hepatol       Date:  2018-06-05       Impact factor: 25.083

6.  Liver Involvement in Children with Alpha-1 Antitrypsin Deficiency: A Multicenter Study.

Authors:  Murat Cakir; Elif Sag; Ali Islek; Masallah Baran; Gokhan Tumgor; Sema Aydogdu
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2020-03-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.